CoChat

Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit

Open access
López-Campos, Jose Luis, Hartl, Sylvia, Pozo-Rodriguez, Francisco, Roberts, C. Michael, on behalf of the European COPD Audit team · 2015 · PLOS ONE

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Appropriate use of antibiotics in the management of hospitalised patients with COPD exacerbations is defined within the GOLD strategy. This paper analyses the factors associated with antibiotic prescribing in patients to better understand how prescribing may be improved. METHODS: The European COPD audit was a study of clinical care in 384 hospitals from 13 European countries between 2010 and 2011 enrolling 16018 patients. Those admitted to hospital due to a clinician-made diagnosis of exacerbation of COPD at the time of discharge were audited. We defined antibiotic prescribing compliance as consistent with the GOLD 2010 recommendations. Two different multivariate models were used to evaluate factors associated with the prescription of antibiotics and the guideline-compliant prescriptions. RESULTS: Overall 86% of admissions were given antibiotics but only 61.4% cases met the GOLD recommendations. Antibiotics were more likely to be given in hospital and at discharge if received prior to admission. Antibiotic prescription was more likely in patients who met the GOLD recommendations and in those with radiological consolidation but there was also a significant use of antibiotics in patients who did not meet either criterion. Patients cared for on a Respiratory Ward were more likely to receive GOLD compliant antibiotic management. CONCLUSIONS: The present study describes the audited in-hospital antibiotic prescription for COPD exacerbation across different European countries. In general, there is an apparent overuse of antibiotics likely to be associated with both patient and practice-related variables.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0124374

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Distribution of antibiotic prescription (A) and correct antibiotic prescription (B) between the participant countries. Red represent those countries with an average value significantly lower than the European average. Yellow represent those countries not significantly different from the European average. Green represent those countries with an average value significantly higher than the European average. White countries did not participate in the audit. Figure for illustrative purposes only.
Fig 1 Distribution of antibiotic prescription (A) and correct antibiotic prescription (B) between the participant countries. Red represent those countries with an average value significantly lower than the European average. Yellow represent those countries not significantly different from the European average. Green represent those countries with an average value significantly higher than the European average. White countries did not participate in the audit. Figure for illustrative purposes only.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 59

Metadata

Authors
López-Campos, J. L., Hartl, S., Pozo-Rodriguez, F., Roberts, C. M., & on behalf of the European COPD Audit team
Affiliations
  • Ludwig Boltzmann Institute for Lung Health (AT)
  • University of London (GB)
Venue
PLOS ONE
Published
2015-04-23
Volume
10
Issue
4
Pages
e0124374
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2028953801
Cited by
59
References
27
Citations by year
2026: 3 · 2025: 6 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 6 · 2018: 9 · 2017: 6 · 2016: 3
FWCI
4.74
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, other-oa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • AstraZeneca
  • GlaxoSmithKline
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
Keywords
COPD exacerbations, antibiotic prescribing, guideline adherence, antibiotic overuse, hospitalized patients
MeSH terms
Anti-Bacterial Agents, Europe, Humans, Medical Audit, Patient Admission, Drug Utilization Review, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit. https://app.cochat.ai/papers/10.1371/journal.pone.0124374
The paper
López-Campos, J. L., Hartl, S., Pozo-Rodriguez, F., Roberts, C. M., & on behalf of the European COPD Audit team. (2015). Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit. PLOS ONE. https://doi.org/10.1371/journal.pone.0124374

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.